GL Capital (德福资本) is a Greater China healthcare-focused, value-driven investment management group.
Phone:
China
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-08-22 | Oxford BioDynamics | PIPE | $12.91M | |
| 2018-06-12 | JINXIN Healthcare | Private Equity | Capital Group Private Markets | |
| 2017-10-13 | SciClone Pharmaceuticals | Take Private | Ascendent Capital Partners, Bank of China, CDH Investments, and Weihang Zhu | |
| 2017-03-15 | Shandong Luoxin Pharmacy Group | Take Private | Ally Bridge Group, and Management Buyout (MBO) | |
| 2011-11-21 | eSilicon | Series G | $2.02M | Crescendo Ventures, Crosspoint Venture Partners, Fremont Ventures, and Investor Growth Capital |
